BIO-RAD Laboratories executive Barry James exercised Options for 425 shares at $0 per share on 2026-09-01. For investors, the transaction records a specific executive Equity movement and identifies the exercise price, while a separate share transaction connected to James was recorded at $380.96 per share.
Key Highlights
- Barry James holds the roles of executive vice president and president of LSG at BIO-RAD Laboratories.
- The related share transaction was recorded at $380.96 per share.
- The option exercise took place on 1 September 2026.
BIO-RAD LABORATORIES, INC. (NYSE: BIO) recorded an option exercise by Barry James covering 425 shares at $0 per share. James is the company’s executive vice president and president of LSG, and the transaction occurred on 1 September 2026.
$0 Option Exercise Recorded The
transaction involved options for 425 BIO-RAD shares and carried a stated exercise price of $0 per share. The transaction was classified as an option exercise. BIO-RAD also recorded a separate share forfeiture involving James at $380.96 per share on the same date. The per-share value applies to that forfeiture transaction, rather than to the option exercise. James’ reported executive positions are executive vice president and president of LSG. The reported transactions concern both BIO-RAD common shares and derivative securities.
FAQs
Q: How many BIO-RAD shares did Barry James exercise?
A: Barry James exercised options covering 425 BIO-RAD Laboratories shares. The stated exercise price was $0 per share, and the transaction occurred on 1 September 2026.
Q: What was the BIO-RAD option exercise price?
A: The BIO-RAD option exercise carried a price of $0 per share. A separate share forfeiture involving Barry James was recorded at $380.96 per share.
Q: When did Barry James complete the BIO-RAD transaction?
A: Barry James completed the BIO-RAD Laboratories option exercise on 1 September 2026. He serves as executive vice president and president of LSG.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.